Azatadine Maleate
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H317301

CAS#: 3978-86-7

Description: Azatadine dimaleate is an antihistamine and anticholinergic inhibitor. It is used for treating allergic rhinitis and chronic urticaria.


Chemical Structure

img
Azatadine Maleate
CAS# 3978-86-7

Theoretical Analysis

Hodoodo Cat#: H317301
Name: Azatadine Maleate
CAS#: 3978-86-7
Chemical Formula: C28H30N2O8
Exact Mass: 522.20
Molecular Weight: 522.550
Elemental Analysis: C, 64.36; H, 5.79; N, 5.36; O, 24.49

Price and Availability

Size Price Availability Quantity
20mg USD 210 2 Weeks
50mg USD 280 2 Weeks
250mg USD 380 2 Weeks
Bulk inquiry

Synonym: Azatadine Maleate; azatadine; azatadine maleate; Idulamine; Idulian; Juste brand of azatadine maleate; Key brand of azatadine maleate; Lergocil; Optimine; Schering brand of azatadine maleate; Schering-Plough brand of azatadine maleate; Zadine

IUPAC/Chemical Name: 6,11-Dihydro-11-(1-methylpiperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine dimaleate

InChi Key: SGHXFFAHXTZRQM-SPIKMXEPSA-N

InChi Code: InChI=1S/C20H22N2.2C4H4O4/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19;2*5-3(6)1-2-4(7)8/h2-7,12H,8-11,13-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-

SMILES Code: CN1CC/C(CC1)=C2C3=CC=CC=C3CCC4=CC=CN=C4\2.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 522.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Azatadine. 2021 Sep 20. PMID: 30000097.


2: Baroody FM, Naclerio RM. Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55 Suppl 64:17-27. doi: 10.1034/j.1398-9995.2000.00803.x. PMID: 11291777.


3: Hillas JL, Somerfield SD, Wilson JD, Aman MG. Azatadine maleate in perennial allergic rhinitis: effects on clinical symptoms and choice reaction time. Br J Clin Pharmacol. 1980 Dec;10(6):573-7. doi: 10.1111/j.1365-2125.1980.tb00513.x. PMID: 7008821; PMCID: PMC1430221.


4: Lin C, Lim J, Symchowicz S. Bioavailability of d-pseudoephedrine and azatadine from a repeat action tablet formulation. J Int Med Res. 1982;10(2):122-5. doi: 10.1177/030006058201000210. PMID: 7067923.


5: Joske DJ. Dystonic reaction to azatadine. Med J Aust. 1984 Sep 29;141(7):449. doi: 10.5694/j.1326-5377.1984.tb132861.x. PMID: 6472185.


6: Biehl B. Effects of azatadine maleate on subjective appraisal and psychomotor functions relevant to driving performance. Curr Med Res Opin. 1979;6(1):62-9. doi: 10.1185/03007997909109399. PMID: 37045.


7: Zubizaretta J. Azatadine maleate/pseudoephedrine sulfate repetabs versus placebo in the treatment of severe perennial allergic rhinitis. J Int Med Res. 1980;8(6):395-9. doi: 10.1177/030006058000800605. PMID: 6108263.


8: Zhu YR, Jia YY, Jiang L, Wang C, Ding LK, Yang J, Li L, Zhao PX, Liu WX, Yi- Ding, Wang L, Wen AD. Determination of azatadine in human plasma by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2189-93. doi: 10.1016/j.jchromb.2011.05.050. Epub 2011 Jun 12. PMID: 21737359.


9: Azatadine (optimine)--a new antihistamine. Med Lett Drugs Ther. 1977 Sep 23;19(19):77-9. PMID: 19692.


10: Zhang D, Hansen EB Jr, Deck J, Heinze TM, Sutherland JB, Cerniglia CE. Fungal biotransformation of the antihistamine azatadine by Cunninghamella elegans. Appl Environ Microbiol. 1996 Sep;62(9):3477-9. doi: 10.1128/aem.62.9.3477-3479.1996. PMID: 8795241; PMCID: PMC168147.


11: Tarasido JC. Azatadine maleate/pseudoephedrine sulfate repetabs versus placebo in the treatment of severe seasonal allergic rhinitis. J Int Med Res. 1980;8(6):391-4. doi: 10.1177/030006058000800604. PMID: 6108262.


12: Togias AG, Naclerio RM, Warner J, Proud D, Kagey-Sobotka A, Nimmagadda I, Norman PS, Lichtenstein LM. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10;255(2):225-9. PMID: 2416958.


13: Katelaris C. Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis. Asian Pac J Allergy Immunol. 1990 Dec;8(2):103-7. PMID: 1982614.


14: Kaminszczik I, Barbon L. Relieving symptoms of upper respiratory allergies and the common cold: azatadine maleate/pseudoephedrine sulfate syrup versus placebo. J Int Med Res. 1983;11(2):101-7. doi: 10.1177/030006058301100207. PMID: 6133802.


15: Alton KB, Petruzzi RF, Patrick JE. High-performance liquid chromatographic assay for azatadine in human urine. J Chromatogr. 1987 Jan 9;385:249-59. doi: 10.1016/s0021-9673(01)94637-0. PMID: 2881936.


16: Tozzi S, Roth FE, Tabachnick II. The pharmacology of azatadine, a potential antiallergy drug. Agents Actions. 1974 Oct;4(4):264-70. doi: 10.1007/BF01965229. PMID: 4155594.


17: Keene AT, Chard CL, Daniels VG. General practitioner surveillance of azatadine maleate/pseudoephedrine sulphate ('Congesteze') for the treatment of upper respiratory tract congestion. Pharmatherapeutica. 1984;3(10):657-62. PMID: 6547778.


18: Kaplan AP. Exercise-induced hives. J Allergy Clin Immunol. 1984 May;73(5 Pt 2):704-7. doi: 10.1016/0091-6749(84)90310-5. PMID: 6371106.


19: Wilson JD, Hillas JL, Somerfield SD. Azatadine maleate (Zadine): evaluation in the management of allergic rhinitis. N Z Med J. 1981 Aug 12;94(689):79-81. PMID: 7024868.


20: Lehrer JF. Inhibition of mediator release by azatadine. JAMA. 1986 Jun 27;255(24):3366-7. doi: 10.1001/jama.1986.03370240036028. PMID: 3712694.